Oncolytic Virotherapy and the Tumor Microenvironment.

about

Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour

P2860

Q57174410-0FA01F76-4D20-45D8-B489-1FDBB39357D5

P2860

Oncolytic Virotherapy and the Tumor Microenvironment.

Item

http://www.wikidata.org/entity/Q47560690

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Oncolytic Virotherapy and the Tumor Microenvironment.

@en

Oncolytic Virotherapy and the Tumor Microenvironment.

@nl

type

Item

label

Oncolytic Virotherapy and the Tumor Microenvironment.

@en

Oncolytic Virotherapy and the Tumor Microenvironment.

@nl

prefLabel

Oncolytic Virotherapy and the Tumor Microenvironment.

@en

Oncolytic Virotherapy and the Tumor Microenvironment.

@nl

P1476

Oncolytic Virotherapy and the Tumor Microenvironment.

@en

P2093

David L Bartlett

http://www.w3.org/2001/XMLSchema#string

Sara E Berkey

http://www.w3.org/2001/XMLSchema#string

Steve H Thorne

http://www.w3.org/2001/XMLSchema#string

P2860

Oncolytic viruses as therapeutic cancer vaccines

Thunder and lightning: immunotherapy and oncolytic viruses collide

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer

Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.

Stepwise release of biologically active HMGB1 during HSV-2 infection.

Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapy

P304

157-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/978-3-319-67577-0_11

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1036

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29275471

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

Oncolytic Virotherapy and the Tumor Microenvironment.

about

P2860

P2860

Oncolytic Virotherapy and the Tumor Microenvironment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921